Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.
2.

Pitavastatin: novel effects on lipid parameters.

Chapman MJ.

Atheroscler Suppl. 2011 Nov;12(3):277-84. doi: 10.1016/S1567-5688(11)70887-X. Review.

PMID:
22152282
3.

Prevalence of dyslipidemia in iran: a systematic review and meta-analysis study.

Tabatabaei-Malazy O, Qorbani M, Samavat T, Sharifi F, Larijani B, Fakhrzadeh H.

Int J Prev Med. 2014 Apr;5(4):373-93. Review.

4.

Prevalence of dyslipidemia in Iranian children and adolescents: A systematic review.

Hovsepian S, Kelishadi R, Djalalinia S, Farzadfar F, Naderimagham S, Qorbani M.

J Res Med Sci. 2015 May;20(5):503-21. Review.

5.

The current state of dyslipidemia in Korean children and adolescents and its management in clinical practice.

Lim JS.

Ann Pediatr Endocrinol Metab. 2013 Mar;18(1):1-8. doi: 10.6065/apem.2013.18.1.1. Epub 2013 Mar 31. Review.

6.

Dyslipidemia in children and adolescents: when and how to diagnose and treat?

Yoon JM.

Pediatr Gastroenterol Hepatol Nutr. 2014 Jun;17(2):85-92. doi: 10.5223/pghn.2014.17.2.85. Epub 2014 Jun 30. Review.

7.

2015 Korean Guidelines for the Management of Dyslipidemia: Executive Summary (English Translation).

Committee for the Korean Guidelines for the Management of Dyslipidemia.

Korean Circ J. 2016 May;46(3):275-306. doi: 10.4070/kcj.2016.46.3.275. Epub 2016 May 27. Review. No abstract available.

Supplemental Content

Support Center